Atopic Dermatitis study: Mindfulness Meditation Sheet
Official title Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
ClinicalTrials.gov ID: NCT07746427
What this study is testing
- What it's testing
- The study wants to see if using a mindfulness meditation app can help control eczema symptoms and improve quality of life in adolescents.
- Who it's for
- It is looking for teens who have moderate to severe atopic dermatitis (eczema).
- What's involved
- Participants will use a digital meditation app regularly and complete surveys about their skin and well‑being. They may also have routine check‑ups with the study team.
- Time commitment
- The study lasts several weeks to months, with regular app use and periodic visits or phone check‑ins to track progress.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 17
You may be able to join if
- Adolescents age 13-17 years.
- Atopic dermatitis refractory to standard topical treatment including topical steroids or topical calcineurin inhibitors.
- Moderate to severe atopic dermatitis via PO-SCORAD score on enrollment.
You likely can't join if
- Started on a biologic agent (i.e. dupxient) within the past 3 months.
- Mild atopic dermatitis via PO-SCORAD score on enrollment.
The study team makes the final eligibility decision.
Where it is enrolling
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New York, New York, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.